FDA Inspection 1264243 — Minsheng Group Shaoxing Pharmaceutical Co., Ltd.

Minsheng Group Shaoxing Pharmaceutical Co., Ltd. — FEI 3004986788

The FDA completed an inspection of Minsheng Group Shaoxing Pharmaceutical Co., Ltd. on November 15, 2024 in Shaoxing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 15, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Shaoxing (China)